NR4A1 and neoplasm: Log-rank tests and univariate Cox regression analyses revealed significant differences in survival rates across various factors (all p<0.001), with menopausal status, tumor size, lymph node involvement, tumor grade, molecular subtypes, histological type, hormone receptor status, and overall survival status (month) influencing RFS.